• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Increased dipropylacetic acid bioavailability from dipropylacetamide by food.

作者信息

Pisani F, D'Agostino A A, Fazio A, Oteri G, Primerano G, Di Perri R

出版信息

Epilepsia. 1982 Apr;23(2):115-21. doi: 10.1111/j.1528-1157.1982.tb05059.x.

DOI:10.1111/j.1528-1157.1982.tb05059.x
PMID:6804222
Abstract

The present study was designed to investigate the influence of food on dipropylacetic acid (DPA) absorption from dipropylacetamide (DPM). Six healthy male volunteers received at weekly intervals, in a crossover randomized fashion, a single oral dose of 60 mg DPM, as 2 X 300-mg capsules, in a fasting state and after a standard meal. In the latter state, the lag time of DPA appearance in the serum increased significantly (p less than 0.02) from 0.6 +/- 0.2 to 2.3 +/- 1.2 h (mean values +/- SD). Maximal DPA serum levels and bioavailability increased significantly (p less than 0.05), with mean values of 27.7 +/- 19.8 and 19.0 +/- 14.7%, respectively, following food. The slower gastric emptying with a consequent improved DPM exposure to metabolizing enzymes and changes in gastric pH probably accounted for these findings. These results suggest that it is more advantageous to take DPM after meals. This helps to reduce gastrointestinal disturbances and to promote DPA absorption.

摘要

相似文献

1
Increased dipropylacetic acid bioavailability from dipropylacetamide by food.
Epilepsia. 1982 Apr;23(2):115-21. doi: 10.1111/j.1528-1157.1982.tb05059.x.
2
Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide.
Ther Drug Monit. 1981;3(3):297-301. doi: 10.1097/00007691-198103000-00012.
3
Plasma level of dipropylacetamide and dipropylacetic acid and effect of these drugs on 5-hydroxytryptamine metabolism in mouse brain.
Biomed Pharmacother. 1986;40(5):191-3.
4
EEG and anticonvulsant effects of dipropylacetic acid and dipropylacetamide in the baboon Papio papio.
Electroencephalogr Clin Neurophysiol. 1980 Aug;49(3-4):391-400. doi: 10.1016/0013-4694(80)90235-7.
5
Intra-daily oscillations in dipropylacetic acid plasma levels with two or three daily doses of dipropylacetamide in epileptic patients.
Ital J Neurol Sci. 1983 Jun;4(2):173-7. doi: 10.1007/BF02043901.
6
Preliminary data on dipropylacetamide absorption in rats.
Boll Soc Ital Biol Sper. 1980 Aug 15;56(15):1541-5.
7
Bioavailability of valproic acid under fasting/nonfasting regimens.
J Clin Pharmacol. 1980 Jan;20(1):30-6. doi: 10.1002/j.1552-4604.1980.tb01663.x.
8
Meal-dependent absorption of enteric-coated sodium valproate.
Epilepsia. 1980 Jun;21(3):273-80. doi: 10.1111/j.1528-1157.1980.tb04073.x.
9
A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats.
J Pharm Pharmacol. 1982 Jan;34(1):45-6. doi: 10.1111/j.2042-7158.1982.tb04676.x.
10
[On the enteral absorption of valproic acid (author's transl)].
Arzneimittelforschung. 1977;27(5):1088-90.

引用本文的文献

1
Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers.
Eur J Clin Pharmacol. 1984;27(4):501-3. doi: 10.1007/BF00549603.
2
Intra-daily oscillations in dipropylacetic acid plasma levels with two or three daily doses of dipropylacetamide in epileptic patients.
Ital J Neurol Sci. 1983 Jun;4(2):173-7. doi: 10.1007/BF02043901.
3
Clinical pharmacokinetics of valproic acid--1988.丙戊酸的临床药代动力学——1988年
Clin Pharmacokinet. 1988 Dec;15(6):367-89. doi: 10.2165/00003088-198815060-00002.
4
Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity.一系列具有抗癫痫活性的丙戊酰胺衍生物的结构-药代动力学关系
Pharm Res. 1989 Aug;6(8):683-9. doi: 10.1023/a:1015934321764.
5
Clinical pharmacology of valpromide.
Clin Pharmacokinet. 1991 Feb;20(2):114-22. doi: 10.2165/00003088-199120020-00003.